Guardian Pharmacy Services (NYSE:GRDN) Receives New Coverage from Analysts at Stephens

Research analysts at Stephens initiated coverage on shares of Guardian Pharmacy Services (NYSE:GRDNGet Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The firm set an “overweight” rating and a $21.00 price target on the stock. Stephens’ price target would indicate a potential upside of 18.18% from the company’s previous close.

GRDN has been the subject of a number of other research reports. Truist Financial assumed coverage on Guardian Pharmacy Services in a report on Monday. They issued a “buy” rating and a $22.00 target price for the company. Raymond James initiated coverage on shares of Guardian Pharmacy Services in a research note on Monday. They set an “outperform” rating and a $21.00 price objective for the company.

Read Our Latest Stock Report on Guardian Pharmacy Services

Guardian Pharmacy Services Trading Down 1.3 %

GRDN opened at $17.77 on Tuesday. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $20.10.

Insider Buying and Selling at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of Guardian Pharmacy Services stock in a transaction dated Friday, September 27th. The shares were purchased at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the acquisition, the director now owns 35,714 shares in the company, valued at $499,996. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Guardian Pharmacy Services stock. Allspring Global Investments Holdings LLC bought a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDNFree Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 325,000 shares of the company’s stock, valued at approximately $5,460,000. Allspring Global Investments Holdings LLC owned 0.52% of Guardian Pharmacy Services as of its most recent filing with the Securities and Exchange Commission (SEC).

About Guardian Pharmacy Services

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Featured Stories

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.